On September 19, Rivkin Radler’s Jeff Kaiser will participate on a panel at Practising Law Institute’s “Life Sciences 2024: Navigating Legal Challenges in Drug and Device Industries” program in New York City.
Held at PLI’s NY Conference Center at 1177 Avenue of the Americas and also available to view online, the program will cover the relationship of FDA and courts, the explosive growth of digital health and the legal and regulatory issues that come with it; clinical trial diversity and reforms; the latest developments in FDA compliance priorities; and recent trends in pricing and reimbursement, effective compliance and investigation practices, and enforcement.
Jeff’s panel is entitled “Enforcement Trends Impacting the Drug and Device Industries.”
For information and to register, click here.
Sign up to receive Rivkin Rounds at www.RivkinRounds.com.